| Smuggling drugs into the brain: An overview of ligands targeting transcytosis for drug delivery across the blood–brain barrier JV Georgieva, D Hoekstra, IS Zuhorn Pharmaceutics 6 (4), 557-583, 2014 | 238 | 2014 |
| Surface characteristics of nanoparticles determine their intracellular fate in and processing by human blood–brain barrier endothelial cells in vitro JV Georgieva, D Kalicharan, PO Couraud, IA Romero, B Weksler, ... Molecular Therapy 19 (2), 318-325, 2011 | 238 | 2011 |
| Peptide-mediated blood-brain barrier transport of polymersomes JV Georgieva, RP Brinkhuis, K Stojanov, CAGM Weijers, H Zuilhof, ... | 142 | 2012 |
| In vivo biodistribution of prion-and GM1-targeted polymersomes following intravenous administration in mice K Stojanov, JV Georgieva, RP Brinkhuis, JC van Hest, FP Rutjes, ... Molecular pharmaceutics 9 (6), 1620-1627, 2012 | 66 | 2012 |
| Identification of variable lymphocyte receptors that can target therapeutics to pathologically exposed brain extracellular matrix BJ Umlauf, PA Clark, JM Lajoie, JV Georgieva, S Bremner, BR Herrin, ... Science Advances 5 (5), eaau4245, 2019 | 23 | 2019 |
| Antibody screening using a human iPSC-based blood-brain barrier model identifies antibodies that accumulate in the CNS JV Georgieva, LI Goulatis, CC Stutz, SG Canfield, HW Song, ... FASEB journal: official publication of the Federation of American Societies …, 2020 | 18 | 2020 |
| Coupling brain perfusion screens and next generation sequencing to identify blood–brain barrier binding antibodies CC Stutz, JV Georgieva, EV Shusta AIChE Journal 64 (12), 4229-4236, 2018 | 13 | 2018 |
| The 46.1 antibody mediates neurotensin uptake into the CNS and the effects depend on the route of intravenous administration JV Georgieva, M Katt, Z Ye, BJ Umlauf, CJ Wenthur, EV Shusta Pharmaceutics 14 (8), 1706, 2022 | 6 | 2022 |
| Ligand-mediated transport of drug delivery devices across the blood-brain barrier JV Georgieva | 2 | 2012 |
| Human blood-brain barrier targeting antibodies EV Shusta, CC Stutz, L Goulatis, J Georgieva US Patent App. 17/759,854, 2023 | | 2023 |
| EXTH-67. IDENTIFICATION AND DEVELOPMENT OF NEURAL ECM-BINDING LAMPREY ANTIBODIES (VARIABLE LYMPHOCYTE RECEPTORS) THAT TARGET GLIOBLASTOMA B Umlauf, P Clark, J Lajoie, J Georgieva, S Bremner, B Herrin, E Shusta, ... Neuro-Oncology 21 (Suppl 6), vi96, 2019 | | 2019 |
| Neural stem cell plasma membrane vesicles as effective nanocarriers for drug delivery into the brain K Stojanov, JV Georgieva, D Hoekstra, IS Zuhorn | | |
